Skip to content

Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service

Recognition and Treatment of Dysglycemia in Elective Knee and Hip Arthroplasties. AGS - Acute Glucose Service

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03306810
Acronym
AGS
Enrollment
600
Registered
2017-10-11
Start date
2017-09-26
Completion date
2025-12-31
Last updated
2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Dysglycemia

Keywords

Perioperative complications, Dysglycemia management team, Nurse Practitioner, Hospital

Brief summary

AGS (Acute Glucose Service ) is an inpatient glucose management service consisting of Nurse Practitioner and physician. Team manages not - consulted- based preoperative assessment, perioperative glucose control, patient education and supervision, but also transition of care postoperatively. The goal is to detect and treat dysglycemias , but also provide an active and constantly ongoing education to other hospital teams. AGS improves better overall- survival of arthroplastic patients and is an effective way to recognize and treat dysglycemias and to organize constantly ongoing education.

Detailed description

600 elective knee and hip arthroplastic patients are collected. 200 patients before AG- service will be compared to 400 patients after AGS. The latter group is divided to two 200 patients groups: 1) with AGS 2) with AGS extended to first control in 3 months (AG- nurse may be contacted by phone). Patients are followed up up to 5 years. Controls will be held after 3 months, 1 year and 5 years after operation including B-Hba1c, 15 D Quality of life assessment and patient interview. There are several aims of the team and study: to detect, diagnose and optimize treatment (including medication) of diabetic/ dysglycemic patients from preoperative assessment 1 week before operation to postoperative care. With blood glucose target 42 - 86 mmol/mol results better overall survival, lesser complications (i.e. infections, cardiovascular or renal complications) and shorter length of hospital stay. Other aim is to find undiagnosed diabetics or those at risk of developing diabetes. One aim is to find risk factors, which lead to stress hyperglycemia during perioperative period or diabetes in 5 years.

Interventions

OTHERAG service

The AG service group is divided to two 200 patients groups: 1) with AGS 2) with AGS extended to first control in 3 months (AG- nurse may be contacted by phone). Patients are followed up up to 5 years.

Sponsors

Joint Authority for Päijät-Häme Social and Health Care
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged \> 18 years * Elective knee and hip arthroplasty patients

Exclusion criteria

* Patients who are incompetent to give informed consent * Patients who are incompetent to assess their Quality-of-Life personally

Design outcomes

Primary

MeasureTime frameDescription
Survival1-5 yearsImproved survival

Secondary

MeasureTime frameDescription
Complications1-5 yearsLess complications after AG-service

Countries

Finland

Contacts

Primary ContactMarianne Ylikoski, MD
marianne.ylikoski@phhyky.fi+358447195268
Backup ContactRaine Tiihonen, MD, PhD
raine.tiihonen@phhyky.fi+358444406151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026